Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.41 USD | +1.94% | -0.70% | 0.00% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
470M | - | - | - | - | - | |
121B | ||||||
114B | ||||||
23.61B | - | |||||
20.43B | - | |||||
16.55B |